X0306 4/A 2020-09-25 2020-09-29 0 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001207833 ORONSKY ARNOLD L C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512 1 0 1 0 Common Stock 2020-09-25 4 P 0 55555 18.00 A 55555 I See footnote Common Stock 2020-09-29 4 C 0 1620101 A 1675656 I See footnote Common Stock 2020-09-29 4 C 0 3488398 A 5164054 I See footnote Common Stock 2020-09-29 4 C 0 1040654 A 6204708 I See footnote Common Stock 2020-09-29 4 C 0 265203 A 6469911 I See footnote Series Seed Preferred Stock 2020-09-29 4 C 0 1620101 0.00 D Common Stock 1620101 0 I See footnote Series A Preferred Stock 2020-09-29 4 C 0 3488398 0.00 D Common Stock 3488398 0 I See footnote Series B Preferred Stock 2020-09-29 4 C 0 1040654 0.00 D Common Stock 1040654 0 I See footnote Series C Preferred Stock 2020-09-29 4 C 0 265203 0.00 D Common Stock 265203 0 I See footnote The shares are directly held by InterWest Partners X, LP ("InterWest X"). InterWest Management Partners X, LLC ("IMP X"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. This Form 4/A has been filed to correct an error in the number of shares reported as purchased by IW10 on September 25, 2020. /s/ Karen Wilson, Attorney-in-Fact for Arnold L. Oronsky 2020-10-02